Table 1 Represents the encapsulation efficiency of CUR NP 7:3 and CUR NP 6:4.
From: PGMD/curcumin nanoparticles for the treatment of breast cancer
Formulations | Polymer (mg/mL) | Drug (mg/mL) | Volume ratio of aqueous and organic phase | Encapsulation efficiency (%) |
|---|---|---|---|---|
CUR NP 7:3 | 10 | 1 | 5:1 | 81.6 |
CUR NP 6:4 | 10 | 1 | 5:1 | 76.51 |
